|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Collaboration revenue | |||||
| Total collaboration revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (income) expense, net | |||||
| Interest expense | |||||
| Net loss and comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | |||||
| Weighted-average number of common shares outstanding, basic and diluted (in shares) | |||||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | |||||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | |||||
| Weighted-average number of common shares outstanding, basic (in shares) | |||||
| Weighted-average number of common shares outstanding, diluted (in shares) | |||||
Loading...
